221 related articles for article (PubMed ID: 17300184)
1. Antitumor potential of crown ethers: structure-activity relationships, cell cycle disturbances, and cell death studies of a series of ionophores.
Marjanović M; Kralj M; Supek F; Frkanec L; Piantanida I; Smuc T; Tusek-Bozić L
J Med Chem; 2007 Mar; 50(5):1007-18. PubMed ID: 17300184
[TBL] [Abstract][Full Text] [Related]
2. Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns.
Supek F; Ramljak TŠ; Marjanović M; Buljubašić M; Kragol G; Ilić N; Smuc T; Zahradka D; Mlinarić-Majerski K; Kralj M
Eur J Med Chem; 2011 Aug; 46(8):3444-54. PubMed ID: 21628081
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives.
Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A
J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122
[TBL] [Abstract][Full Text] [Related]
4. Nanoscale tools to selectively destroy cancer cells.
Boudreault PL; Arseneault M; Otis F; Voyer N
Chem Commun (Camb); 2008 May; (18):2118-20. PubMed ID: 18438487
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of aza-crown ether-squaramide conjugates as anion/cation symporters.
Yu XH; Cai XJ; Hong XQ; Tam KY; Zhang K; Chen WH
Future Med Chem; 2019 May; 11(10):1091-1106. PubMed ID: 31280669
[No Abstract] [Full Text] [Related]
7. Syntheses and antiproliferative activities of 7-azarebeccamycin analogues bearing one 7-azaindole moiety.
Marminon C; Pierré A; Pfeiffer B; Pérez V; Léonce S; Joubert A; Bailly C; Renard P; Hickman J; Prudhomme M
J Med Chem; 2003 Feb; 46(4):609-22. PubMed ID: 12570382
[TBL] [Abstract][Full Text] [Related]
8. Role of crown-like side chains in the biological activity of substituted-phenoxazone drugs.
Karawajew L; Glibin EN; Maleev VY; Czerwony G; Dörken B; Davies DB; Veselkov AN
Anticancer Drug Des; 2000 Oct; 15(5):331-8. PubMed ID: 11354309
[TBL] [Abstract][Full Text] [Related]
9. Convenient approaches to synthesis of furanoid sugar-aza-crown ethers from C-ribosyl azido aldehyde via a reductive amination/amidation.
Hsieh YC; Chir JL; Zou W; Wu HH; Wu AT
Carbohydr Res; 2009 May; 344(8):1020-3. PubMed ID: 19362710
[TBL] [Abstract][Full Text] [Related]
10. 3-substituted 7-phenyl-pyrroloquinolinones show potent cytotoxic activity in human cancer cell lines.
Gasparotto V; Castagliuolo I; Ferlin MG
J Med Chem; 2007 Nov; 50(22):5509-13. PubMed ID: 17915851
[TBL] [Abstract][Full Text] [Related]
11. Triphenylmethylamides (TPMAs): Structure-activity relationship of compounds that induce apoptosis in melanoma cells.
Palchaudhuri R; Hergenrother PJ
Bioorg Med Chem Lett; 2008 Nov; 18(22):5888-91. PubMed ID: 18710803
[TBL] [Abstract][Full Text] [Related]
12. Double-armed crown ethers for calcium optical sensors.
Capel-Cuevas S; de Orbe-Payá I; Santoyo-González F; Capitán-Vallvey LF
Talanta; 2009 Jun; 78(4-5):1484-8. PubMed ID: 19362220
[TBL] [Abstract][Full Text] [Related]
13. Relationship between structure and antiproliferative activity of 1-azaflavanones.
Kawaii S; Endo K; Tokiwano T; Yoshizawa Y
Anticancer Res; 2012 Jul; 32(7):2819-25. PubMed ID: 22753743
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, Biological Evaluation, and Molecular Modeling of Aza-Crown Ethers.
Basok SS; Schepetkin IA; Khlebnikov AI; Lutsyuk AF; Kirichenko TI; Kirpotina LN; Pavlovsky VI; Leonov KA; Vishenkova DA; Quinn MT
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921479
[TBL] [Abstract][Full Text] [Related]
15. Infrared spectroscopy of ionophore-model systems: hydrated alkali metal ion 18-crown-6 ether complexes.
Rodriguez JD; Vaden TD; Lisy JM
J Am Chem Soc; 2009 Dec; 131(47):17277-85. PubMed ID: 19899741
[TBL] [Abstract][Full Text] [Related]
16. Further Approaches in the Design of Antitumor Agents with Response to Cell Resistance: Looking toward Aza Crown Ether-dtc Complexes.
Arenaza-Corona A; Couce-Fortúnez MD; de Blas A; Morales-Morales D; Santillan R; Höpfl H; Rodríguez-Blas T; Barba V
Inorg Chem; 2020 Oct; 59(20):15120-15134. PubMed ID: 33000942
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
18. Transcription-inhibition and antitumor activities of N-alkylated tetraazacyclododecanes.
Xiong XQ; Liang F; Yang L; Wang XL; Zhou X; Zheng CY; Cao XP
Chem Biodivers; 2007 Dec; 4(12):2791-7. PubMed ID: 18081089
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of new benzodioxinic lactones as potential anticancer drugs.
Romero M; Renard P; Caignard DH; Atassi G; Solans X; Constans P; Bailly C; Pujol MD
J Med Chem; 2007 Jan; 50(2):294-307. PubMed ID: 17228871
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of tumor cell growth inhibition of methyl 3-amino-6-[(hetero)arylethynyl]thieno[3,2-b]pyridine-2-carboxylates. Structure-activity relationships, effects on the cell cycle and apoptosis.
Queiroz MJ; Calhelha RC; Vale-Silva LA; Pinto E; Almeida GM; Vasconcelos MH
Eur J Med Chem; 2011 Jan; 46(1):236-40. PubMed ID: 21138784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
